Clinical trial
LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma
NCT03287947 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 10, 2017
- Completion date
- October 27, 2019
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
appendix cancer